MSD India's Out-Of-The-Box Hep C Financing: How, Why And What Next?
This article was originally published in PharmAsia News
Executive Summary
Merck’s India unit has worked to refine a finance program for Hepatitis C treatments that could rapidly grow patient numbers by solving a financing issue that has bedeviled wider use.